<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 28 Aug 2026 04:42:16 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Opus Genetics (IRD) Reiterated at Market Outperform by Citizens: Focus on Viatris</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Opus+Genetics+%28IRD%29+Reiterated+at+Market+Outperform+by+Citizens%3A+Focus+on+Viatris/26992141.html</link>
   <description>&lt;p&gt;Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $12.00 price target on Opus Genetics (NASDAQ: IRD).&lt;/p&gt;&lt;p&gt;The analyst commented, &quot;Our focus, like that of investors, has been on Opus’ internal programs, and rightfully so, however, we also wanted to take a look at the potential non-dilutive capital on the table from partner Viatris. The royalty revenue from Ryzumvi has been modest to date, but we expect a milestone payment (~$10M) triggered by the October 17 PDUFA for presbyopia, and Viatris has flagged launches next year in presbyopia and dim-light disturbances (DLD) as important value drivers. We do not model</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Opus+Genetics+%28IRD%29+Reiterated+at+Market+Outperform+by+Citizens%3A+Focus+on+Viatris/26992141.html</guid>
   <pubDate>Fri, 28 Aug 2026 04:42:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron names Nirav Jhaveri as CFO</title>
   <link>http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</link>
   <description>

&lt;p&gt;Longeveron Inc. (NASDAQ: LGVN) has appointed Nirav Jhaveri as chief financial officer, principal financial officer, and principal accounting officer, according to a company statement.&lt;/p&gt;

&lt;p&gt;Jhaveri succeeds Marie Washburn, who had served as interim CFO following the retirement of the prior CFO. Washburn will return to her role as corporate controller.&lt;/p&gt;

&lt;p&gt;Jhaveri holds more than 25 years of experience in capital markets, corporate finance, business development, and investor relations, including over 15 years in the biotech sector. He previously served as CFO at Opus Genetics (NASDAQ: IRD), Insilico Medicine (HKEX: 3696.HK), and Journey Medical Corporation (NASDAQ: DERM). Earlier in his career, he held</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Longeveron+names+Nirav+Jhaveri+as+CFO/26950025.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:16 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
  <item>
   <title>Longeveron Appoints Nirav Jhaveri as Chief Financial Officer</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</link>
   <description>
&lt;ul type=&quot;disc&quot;&gt;&lt;li&gt;&lt;em&gt;Mr. Jhaveri has over 25 years of experience in capital markets, corporate finance, business development and investor relations, including more than 15 years in the biotech sector&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p align=&quot;justify&quot;&gt;MIAMI, Aug.  19, 2026  (GLOBE NEWSWIRE) -- &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=ewQsFeRdyZScA6eWNrgObmepp9iCCgr3b_wlxCliEuumzcI-72fNAECHVrDHUun2yGTIt4r-mN51ywtVH6rXp66mpxCczU09HcSH0HIeglc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Longeveron Inc.&lt;/a&gt; (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company has appointed Nirav Jhaveri, CFA, to the Company’s executive leadership team in the role of Chief Financial Officer (“CFO”), principal financial officer and principal accounting officer. He succeeds Marie Washburn who stepped</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Longeveron+Appoints+Nirav+Jhaveri+as+Chief+Financial+Officer/26950020.html</guid>
   <pubDate>Wed, 19 Aug 2026 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">3696</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216935</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DERM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IRD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LGVNR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01227350</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.26057861</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.49866458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.57690994</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O15</category>
   	  </item>
 </channel>
</rss>
